NCT02698527

Brief Summary

Objective: To compare pain scores on a visual analogue scale during infiltration of local anesthetic for vulvar biopsies between women who are treated with buffered versus non- buffered lidocaine Hypothesis: Patients treated with buffered lidocaine at the site of vulvar biopsy will have lower pain scores on a visual analogue scale during the biopsy. Study Design: Double blinded randomized controlled trial Population: Women undergoing vulvar biopsy at the Women's Primary Care Center and The Program In Women's Oncology Clinic of a non-infectious vulvar lesion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2015

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2015

Completed
14 days until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
9 months until next milestone

First Posted

Study publicly available on registry

March 3, 2016

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

October 10, 2018

Status Verified

October 1, 2018

Enrollment Period

2.8 years

First QC Date

May 18, 2015

Last Update Submit

October 7, 2018

Conditions

Keywords

lidocaine

Outcome Measures

Primary Outcomes (3)

  • Pain scores on Visual Analogue Pain Scale (100mm)

    Before procedure, approximately 5 minutes

  • Pain scores on Visual Analogue Pain Scale (100mm)

    During infiltration of lidocaine, approximately 10 minutes

  • Pain scores on Visual Analogue Pain Scale (100mm)

    After completion of procedure, approximately 5 minutes

Study Arms (2)

Non-Buffered Lidocaine

ACTIVE COMPARATOR

Vulvar biopsy conducted using non-buffered lidocaine as anesthesia

Drug: Non-Buffered Lidocaine

Buffered Lidocaine

EXPERIMENTAL

Vulvar biopsy conducted using buffered lidocaine as anesthesia

Drug: Buffered Lidocaine

Interventions

Active comparator

Non-Buffered Lidocaine

Experimental, additIon of Sodium Bicarbonate to Lidocaine

Buffered Lidocaine

Eligibility Criteria

Age18 Years - 99 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient at the Women's Primary Care Center
  • Ages 18 and older
  • Require a vulvar biopsy for a noninfectious vulvar lesion.
  • Able to read English or Spanish
  • Able to give informed consent for involvement in the study

You may not qualify if:

  • Allergy to lidocaine
  • Unable to give informed consent
  • Unable to read English or Spanish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Women and Infants Hospital, Program in Women's Oncology

Providence, Rhode Island, 02905, United States

Location

Women's Primary Care Center/Women and Infants' Hospital

Providence, Rhode Island, 02905, United States

Location

Related Publications (1)

  • Villavicencio JC, Kulkarni A, Luis C, Mendez H, Raker C, Cronin B, Robison K. Sensation of Pain Using Buffered Lidocaine for Infiltration Before Vulvar Biopsy: A Randomized Controlled Trial. Obstet Gynecol. 2020 Mar;135(3):609-614. doi: 10.1097/AOG.0000000000003710.

MeSH Terms

Conditions

Genital Diseases, Female

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Jennifer C Villavicencio, MD

    Women and Infants Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Invesitgator

Study Record Dates

First Submitted

May 18, 2015

First Posted

March 3, 2016

Study Start

June 1, 2015

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

October 10, 2018

Record last verified: 2018-10

Locations